Trial intelligence / Profile preview

Valsartan for Blood Pressure Management in Acute Stroke

NCT01400256Phase 4Withdrawn

Sponsor
Stanford University
Start
Aug 2007
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valsartan in hypertension (HTN), sponsored by Stanford University. Planned start Aug 2007; status: withdrawn.

02

Drugs

valsartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01400256.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01400256.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call